Patents by Inventor Gavin J. Gordon

Gavin J. Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic and prognostic tests
    Patent number: 8551700
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: October 8, 2013
    Assignees: The Brigham and Women's Hospital, Inc., Wesleyan University
    Inventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Li-Li Hsiao, Raphael Bueno
  • Diagnostic tests using gene expression ratios
    Patent number: 8450057
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from cell or tissue samples, such as cancer cell or tissue samples. The invention also provides sets of genes that are expressed differentially in normal and cancer lung cells and tissues. These sets of genes can be used to discriminate between normal and malignant cells or tissues, and between classes of malignant cells or tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: May 28, 2013
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Gavin J. Gordon, Raphael Bueno
  • DIAGNOSTIC AND PROGNOSTIC TESTS
    Publication number: 20110059854
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Application
    Filed: July 12, 2010
    Publication date: March 10, 2011
    Applicants: THE BRIGHAM AND WOMEN'S HOSPITAL, INC., WESLEYAN UNIVERSITY
    Inventors: GAVIN J. GORDON, RODERICK V. JENSEN, STEVEN R. GULLANS, LI-LI HSIAO, RAPHAEL BUENO
  • DIAGNOSTIC TESTS USING GENE EXPRESSION RATIOS
    Publication number: 20100028876
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from cell or tissue samples, such as cancer cell or tissue samples. The invention also provides sets of genes that are expressed differentially in normal and cancer lung cells and tissues. These sets of genes can be used to discriminate between normal and malignant cells or tissues, and between classes of malignant cells or tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumour progression/regression also are provided.
    Type: Application
    Filed: August 8, 2007
    Publication date: February 4, 2010
    Applicant: The Brigham and Women's Hospital , Inc.
    Inventors: Gavin J. Gordon, Raphael Bueno
  • Diagnostic and prognostic tests
    Patent number: 7622260
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: November 24, 2009
    Assignees: The Brigham and Women's Hospital, Inc., Wesleyan University
    Inventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Raphael Bueno, Li-Li Hsiao
  • Diagnostic and Prognostic Tests
    Publication number: 20090104617
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Application
    Filed: December 5, 2008
    Publication date: April 23, 2009
    Applicants: The Brigham And Women's Hospital, Inc., Wesleyan University
    Inventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Li-Li Hsiao, Raphael Bueno
  • Diagnostic and prognostic tests
    Publication number: 20030219760
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Application
    Filed: September 5, 2002
    Publication date: November 27, 2003
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Raphael Bueno